Literature DB >> 26773158

Potential Role of the Formation of Tunneling Nanotubes in HIV-1 Spread in Macrophages.

Michihiro Hashimoto1, Farzana Bhuyan1, Masateru Hiyoshi1, Osamu Noyori1, Hesham Nasser1, Mitsue Miyazaki1, Tamio Saito2, Yasumitsu Kondoh2, Hiroyuki Osada2, Shunsuke Kimura3, Koji Hase3, Hiroshi Ohno3, Shinya Suzu4.   

Abstract

Tunneling nanotubes (TNTs), the long membrane extensions connecting distant cells, have emerged as a novel form of cell-to-cell communication. However, it is not fully understood how and to what extent TNTs contribute to intercellular spread of pathogens including HIV-1. In this study, we show that HIV-1 promotes TNT formation per se via its protein Nef and a cellular protein M-Sec, which appears to mediate approximately half of viral spread among monocyte-derived macrophages (MDMs). A small compound that inhibits M-Sec-induced TNT formation reduced HIV-1 production by almost half in MDMs. Such inhibition was not observed with Nef-deficient mutant HIV-1 that fails to promote TNT formation and replicates less efficiently than the wild-type HIV-1 in MDMs. The TNT inhibitor-sensitive/Nef-promoting viral production was also observed in a T cell line ectopically expressing M-Sec, but not in another M-Sec(-) T cell line. Our results suggest the importance of TNTs in HIV-1 spread among MDMs and might answer the long-standing question how Nef promotes HIV-1 production in a cell type-specific manner.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26773158     DOI: 10.4049/jimmunol.1500845

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes.

Authors:  Jaime Uhl; Shivalee Gujarathi; Abdul A Waheed; Ana Gordon; Eric O Freed; Karine Gousset
Journal:  J Cell Commun Signal       Date:  2018-11-15       Impact factor: 5.782

Review 2.  Bridging the Gap: Virus Long-Distance Spread via Tunneling Nanotubes.

Authors:  Robert J J Jansens; Alexander Tishchenko; Herman W Favoreel
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

3.  Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.

Authors:  Silvana Valdebenito; Daniela D'Amico; Eliseo Eugenin
Journal:  Cancer Rep (Hoboken)       Date:  2019-11-11

4.  Tunneling Nanotubes as a Novel Route of Cell-to-Cell Spread of Herpesviruses.

Authors:  Mirosława Panasiuk; Michał Rychłowski; Natalia Derewońko; Krystyna Bieńkowska-Szewczyk
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

5.  The chaperone ERp29 is required for tunneling nanotube formation by stabilizing MSec.

Authors:  Rajaiah Pergu; Sunayana Dagar; Harsh Kumar; Rajesh Kumar; Jayanta Bhattacharya; Sivaram V S Mylavarapu
Journal:  J Biol Chem       Date:  2019-03-15       Impact factor: 5.157

Review 6.  Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems.

Authors:  Shaily Malik; Eliseo A Eugenin
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

Review 7.  Peering into tunneling nanotubes-The path forward.

Authors:  Diégo Cordero Cervantes; Chiara Zurzolo
Journal:  EMBO J       Date:  2021-03-01       Impact factor: 11.598

Review 8.  Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer.

Authors:  Vaibhav Tiwari; Raghuram Koganti; Greer Russell; Ananya Sharma; Deepak Shukla
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

9.  Utilization of Laser Capture Microdissection Coupled to Mass Spectrometry to Uncover the Proteome of Cellular Protrusions.

Authors:  Ana Gordon; Karine Gousset
Journal:  Methods Mol Biol       Date:  2021

Review 10.  HIV-1 infection of the kidney: mechanisms and implications.

Authors:  Kelly Hughes; Jerry Chang; Hannah Stadtler; Christina Wyatt; Mary Klotman; Maria Blasi
Journal:  AIDS       Date:  2021-03-01       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.